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Abstract. 
 
Caveolin-1 and -2 constitute a framework
of caveolae in nonmuscle cells. In the present study,
 
we showed that caveolin-2, especially its 
 
b
 
 isoform, is
 
targeted to the surface of lipid droplets (LD) by im-
munoﬂuorescence and immunoelectron microscopy,
and by subcellular fractionation. Brefeldin A treatment
induced further accumulation of caveolin-2 along with
caveolin-1 in LD. Analysis of mouse caveolin-2 deletion
mutants revealed that the central hydrophobic domain
 
(residues 87–119) and the NH
 
2
 
-terminal (residues 70–86)
and COOH-terminal (residues 120–150) hydrophilic do-
 
mains are all necessary for the localization in LD. The
 
NH
 
2
 
- and COOH-terminal domains appeared to be
related to membrane binding and exit from ER, re-
spectively, implying that caveolin-2 is synthesized and
 
transported to LD as a membrane protein. In conjunc-
tion with recent ﬁndings that LD contain unesteriﬁed
cholesterol and raft proteins, the result implies that
the LD surface may function as a membrane domain.
It also suggests that LD is related to trafﬁcking of
lipid molecules mediated by caveolins.
Key words: lipid droplet • caveolin-2 • caveolin-1 •
membrane domain • brefeldin A
 
Introduction
 
Caveolae are small invaginations of the plasma mem-
brane, and are assumed to play important roles in signal
transduction, cholesterol transport, and endocytosis (An-
derson, 1998; Fujimoto et al., 1998; Okamoto et al., 1998).
Caveolins are essential for the above functions and form
the structural framework of caveolae (Parton, 1996).
Among caveolin family members, caveolin-1 is sufficient
to induce caveolae formation, binds to cholesterol, and in-
teracts with signaling molecules. Caveolin-3, expressed in
limited kinds of cells, is thought to play a similar role as ca-
veolin-1. In contrast, the function of caveolin-2 has not
been defined in detail, except that recent results implied
its involvement in forming deep caveolae invagination
(Scheiffele et al., 1998; Fujimoto et al., 2000).
In the present study, we found that caveolin-2 can be tar-
 
geted to the surface of lipid droplets (LD).
 
1
 
 LD are found
not only in adipose cells, but also in many other cells under
various conditions. A notable example is the foam cell in
the atheromatous plaque, but the functional significance of
LD has not been known. Our result is consistent with the
assumption that the LD surface is a “half membrane” con-
sisting of a phospholipid monolayer. Interestingly, LD were
reported to contain unesterified cholesterol (Prattes et al.,
2000) and raft proteins related to signaling (Yu et al., 1998,
2000). Based on the findings, we propose that the surface of
LD functions as a membrane domain.
 
Materials and Methods
 
Cell Culture
 
Cells were grown in DME with 10% FCS [HepG2, normal rat kidney
(NRK), and human fibroblast], in Ham’s F-12/DME with 10% horse se-
rum and 2.5% FCS (Y-1), or in Ham’s F-12/Coon’s medium with 5%
horse serum and hormones (FRTL-5). To induce LD formation, cells
were cultured with oleic acid complexed with BSA (OA/BSA) (Bra-
saemle et al., 1997) for 2 d.
 
Transfection
 
Transient cell transfections were done by calcium phosphate or DEAE-
dextran methods. Stably transfected cells were made using Lipo-
fectAMINE 2000 reagent and selected by G418 (GIBCO BRL). Caveo-
lins were cloned by reverse transcriptase PCR from human fibroblasts and
3T3-L1 cells; the standard PCR was used to construct various mutant pro-
teins, which were controlled by sequencing. Enhanced green fluorescent
protein (EGFP) was tagged to the NH
 
2
 
 terminus of caveolin-2 molecules
by using pEGFP vectors (CLONTECH Laboratories, Inc.).
 
Dr. Nomura’s current address is Department of Anatomy, Hiroshima
University School of Medicine, Hiroshima 734-8551, Japan. 
Address correspondence to Toyoshi Fujimoto, Department of Anat-
omy and Molecular Cell Biology, Nagoya University Graduate School of
Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Japan. Tel.: 81 52-744-
2000. Fax: 81 52-744-2011. E-mail: tfujimot@med.nagoya-u.ac.jp
 
1
 
Abbreviations used in this paper:
 
 BFA, brefeldin A; EGFP, enhanced
green fluorescent protein; LD, lipid droplets; NRK, normal rat kidney;
OA, oleic acid. 
The Journal of Cell Biology, Volume 152, 2001 1080
 
Antibodies
 
Antibodies to caveolin-2 (Transduction Laboratories), caveolin-1 (Santa
Cruz Biotechnology, Inc.), adipophilin (Progen), and Na
 
1
 
/K
 
1
 
-ATPase
(Affinity Bioreagents) were purchased. Antibodies to GM130 (Nakamura
et al., 1995), ER (Louvard et al., 1982), and calreticulin (Ioshii et al., 1995)
were donated by Dr. Nobuhiro Nakamura (Kanazawa University,
Kanazawa, Japan), Dr. Daniel Louvard (Institut Curie, Paris, France),
and Dr. Toshimichi Yoshida (Mie University, Mie, Japan), respectively.
Secondary antibodies were bought from Jackson ImmunoResearch Labo-
ratories and Amersham Pharmacia Biotech.
 
Subcellular Fractionation and Western Blotting
 
LD were isolated as described from the nitrogen cavitate (Yu et al., 2000).
Fractions precipitated with TCA were separated by SDS-PAGE, blot to ni-
trocellulose paper, and probed by antibodies. After incubation with HRP-
conjugated antibodies, the reaction was visualized by chemiluminescence.
The protein content was measured by BCA assay (Pierce Chemical Co.).
 
Immunofluorescence Microscopy
 
To localize caveolin-2, cells fixed with 3% formaldehyde were permeabi-
lized either with Triton X-100 for labeling LD and the Golgi, or with
methanol for labeling the plasma membrane. LD was stained with Sudan
III (Chroma) and observed as orange-red fluorescence. Some cells were
treated with BFA (Calbiochem) and nocodazole (ICN Biomedicals) be-
fore fixation. Samples were observed by conventional or by confocal fluo-
rescence microscopy.
 
Immunoelectron Microscopy
 
Cells were fixed in 1% formaldehyde for 15–30 min. For ultrathin cryosec-
tions, cell pellet infiltrated with 2.3 M sucrose was processed by the Toku-
yasu method (Tokuyasu, 1986). For freeze-fracture replicas, cell pellet in-
filtrated with 30% glycerol was freeze-fractured, and platinum/carbon
replicas were labeled as described previously (Fujimoto, 1995).
 
Results
 
Caveolin-2 Is Targeted to LD
 
HepG2 lacks caveolins and has prominent LD in a stan-
dard culture condition. Human caveolin-2
 
b
 
 transfected to
HepG2 showed round-shaped labeling, which was re-
vealed to be around LD by Sudan III staining (Fig. 1 a).
Labeling for caveolin-2 was seen discontinuously around
LD. Four cell lines stably expressing caveolin-2
 
b
 
 gave
equivalent results, and clone A-8 was used for most exper-
iments. Expression of caveolin-2 did not appear to change
the size and number of LD in HepG2. In contrast, human
caveolin-1 transfected to HepG2 was seen in the cell sur-
face and not related to LD (Fig. 1 b). Transfected caveo-
lin-2 also occurred in LD of other cell types. In FRTL-5,
LD were absent in a normal culture condition, and trans-
fected caveolin-2 was seen in the Golgi as reported (not
shown; Mora et al., 1999). But when LD were induced by
OA/BSA, caveolin-2 was observed around them (Fig. 1 c).
Caveolin-2
 
b
 
 in HepG2 was localized almost exclusively in
LD, and the labeling coexisting with that of GM130, a Golgi
protein (Nakamura et al., 1995) was scarce (Fig. 1 d). On
the other hand, transfection of full-length caveolin-2 cDNA
gave rise to prominent Golgi labeling, and LD were labeled
only occasionally (Fig. 1 e). Western blotting showed pre-
dominant caveolin-2
 
a
 
 and little caveolin-2
 
b
 
 in those cells
(not shown). In any cell line described above, neither anti–
GM130 nor anti–ER antibody labeled LD (not shown).
Localization of caveolin-2 in LD was confirmed by im-
munoelectron microscopy. In cryosections, the labeling
was localized along the LD rim, and not in adjacent or-
ganelles (Fig. 2 a). Notably, most gold particles were seen
in small clusters. The localization in LD was even more ev-
ident in freeze-fracture replicas. LD was identified by the
onion-like morphology; the labeling for caveolin-2 also oc-
curred in clusters and was seen only on the
 
 
 
P, but not the
E, face of LD (Fig. 2 b).
The LD localization was also confirmed by subcellular
fractionation (Fig. 2 c). The top two fractions obtained by
ultracentrifugation contained only 1.3% of the total pro-
tein, and were devoid of markers for ER, Golgi, and
plasma membrane. But the fractions were positive for adi-
pophilin, an LD-specific protein, and contained a signifi-
cant amount of caveolin-2.
Figure 1.  Confocal microscopy of HepG2 stably expressing ca-
veolin-2b (a) and caveolin-1 (b). Caveolins (green), LD stained
by Sudan III (red). Caveolin-2 is seen around LD discontinu-
ously, whereas caveolin-1 is along the cell edge, and not related
to LD. (c) FRTL-5 transiently transfected with full-length caveo-
lin-2 cDNA and cultured with OA/BSA for 2 d. Caveolin-2
(green) is observed around LD (red). HepG2 stably transfected
with caveolin-2b (d) or full-length caveolin-2 (e) cDNA was la-
beled for caveolin-2 (green) and GM130 (red). The labeling of
caveolin-2b overlapping with that of GM130 is scarce (d),
whereas caveolin-2a, the predominant isoform in the cell, is
mostly localized in the Golgi (e). Arrows indicate labeling
around LD. Bars, 10 mm. 
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Caveolin-2 was seen in LD even when caveolin-1 is coex-
pressed. EGFP-mouse caveolin-2 transfected to NRK and
Y-1 was recruited to LD (Fig. 3 a). The LD localization of
caveolin-2 was also seen in HepG2 doubly transfected with
untagged caveolin-1 and -2 (clone 6; Fig. 3, b and c). LD
was found in most cells, but LD localization of caveolin-2
was not seen frequently. Notably, in cells showing caveolin-2
in LD, labeling of caveolin-1 was not observed in LD, but
occurred in the plasma membrane. The result was con-
firmed by the lack of caveolin-1 signal in the LD fractions
obtained from the doubly transfected HepG2 (Fig. 3 d).
 
Brefeldin A Causes Accumulation of Caveolins in LD
 
Neither immunofluorescence labeling nor Western blot-
ting of subcellular fractions could detect endogenous cave-
olin-2 in LD of NRK, Y1, or human fibroblasts (not
shown). Predominance of the 
 
a 
 
over the 
 
b
 
 isoform
(Scherer et al., 1997) may be a reason for the negative re-
sult. However, when HepG2 expressing caveolin-2
 
a
 
 was
treated with 5 
 
m
 
g/ml brefeldin A (BFA), the LD distribu-
tion increased drastically within 2 h (Fig. 4 a). When BFA
was applied to human fibroblasts loaded with OA/BSA,
endogenous caveolin-1 and -2 were both labeled in LD
(Fig. 4, b and c). The LD labeling became visible much
earlier for caveolin-2 than for caveolin-1. The result
showed that endogenous caveolin-2 can be detected in LD
when normal trafficking is perturbed by BFA.
Interestingly, the BFA treatment also recruited caveolin-1
to LD in HepG2 expressing caveolin-1 alone (Fig. 4 d). But
the redistribution of caveolin-1 to LD was slow and not de-
tectable at 2 h. Even at 7 h, it was seen only in occasional
cells, and most labeling remained on the cell surface.
 
Sequences Required for Targeting to LD
 
To identify molecular domains required for targeting to
LD, mouse caveolin-2 mutants were constructed (Fig. 5 a)
and transfected transiently to HepG2. First, to examine
whether caveolin-2
 
a
 
 goes to LD, the second methionine
Figure 2. (a and b) Immunoelectron microscopy of HepG2 express-
ing caveolin-2b (clone A-8). Bar, 500 nm. (a) Ultrathin cryosection.
Gold particles labeling caveolin-2 are observed in the rim of LD in
small clusters (arrowheads); the content of LD appears vacant. (b)
Freeze-fracture replica. Gold particles for caveolin-2 are observed in
clusters (arrowheads) on the P face of LD, which show an onion-like
morphology. The E face of LD (E) is devoid of labeling. (c) Western
blotting of subcellular fractions obtained from HepG2 clone A-8. The
graph shows the protein content of the fractions. The top two frac-
tions (#1 and #2) contained little protein, but showed positive signals
for caveolin-2 and adipophilin. GM130, 66-kD protein, and Na1/K1-
ATPase (Golgi, ER, and plasma membrane markers, respectively)
are found only in the bottom fractions. 
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(residue 14) was replaced with leucine to abolish genera-
tion of the 
 
b
 
 isoform. The mutant (M14/L) showed the
dual distribution in the Golgi and LD, proving that the 
 
a
 
isoform can be distributed in LD (Fig. 5 b). Another mu-
tant with glycine (residue 2) replaced with alanine (G2/A)
was made to examine the possible influence of NH
 
2
 
-termi-
nal myristoylation on targeting. G2/A showed a distribu-
tion similar to the intact 
 
a
 
 isoform and thus the myris-
toylation does not account for the preferential Golgi
localization (Fig. 5 b). The result suggests that the 13
amino acids specific to the 
 
a
 
 isoform may reduce the affin-
ity to LD, or may be a strong signal for Golgi localization.
 
Second, NH
 
2
 
 and COOH termini of caveolin-2 were trun-
cated in various lengths. Because NH
 
2
 
-terminal truncation
mutants were not reactive with the anti–caveolin-2 antibody
(Das et al., 1999), they were fused to the COOH terminus
of EGFP (Fig. 5 c). Up to 69 residues from the NH
 
2
 
 termi-
nus could be deleted (70–162) without producing a notable
difference from the intact caveolin-2
 
b
 
, whereas deleting the
70th tryptophan residue (71–162) abolished both LD and
Golgi localization and produced diffuse cytosolic and nu-
clear distribution. On the other hand, COOH-terminal de-
letion caused a gradual change (Fig. 5 d). 12 residues could
be truncated without a visible effect (1–150 and 14–150; not
shown), but by deleting further residues (1–144 to 1–132
and 14–144 to 14–132), localization to LD and Golgi be-
came indistinct, and the cytoplasmic labeling in the network
pattern increased. The cytoplasmic labeling showed colocal-
ization with calreticulin, an ER lumenal protein, implying
Figure 3. (a) NRK, expressing EGFP–caveolin-2 along with en-
dogenous caveolin-1 and -2, cultured with OA/BSA. EGFP-cave-
olin-2 (green) is seen around LD (red) (arrows). (b and c)
HepG2 stably expressing caveolin-1 and -2 (clone 6). Caveolin-1
(red) and -2 (green) show colocalization in the plasma membrane
(b), and only caveolin-2 (green) is observed around LD (red) in
some cells (arrows) (c). Cells in b and c were treated with metha-
nol and Triton X-100, respectively, to show the plasmalemmal
(b) and intracellular (c) labeling. Bars, 10 mm. (d) Western blot-
ting of subcellular fractions obtained from HepG2 clone 6. Only
caveolin-2, but not caveolin-1, was detected in the LD fractions
(#1 and #2).
Figure 4. (a) HepG2 stably transfected with full-length caveolin-2
cDNA was treated with BFA for 2 h. Caveolin-2 (green) became
confined to LD (red) in most cells (arrows). (b and c) Human fi-
broblasts treated with BFA for 16 h. Not only caveolin-2 (b), but
also caveolin-1 (c) (green) was observed around LD (red) (ar-
rows). (d) HepG2 stably transfected with full-length caveolin-1
cDNA. After the BFA treatment for 7 h, caveolin-1 (green) was
seen around LD (red) in occasional cells (arrows). Bars, 10 mm. 
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that it is derived from ER; moreover, by treating cells with
10 
 
m
 
M nocodazole for 2 h, labeling for the caveolin-2 mu-
tants and calreticulin showed a similar retraction from the
cell edge (Fig. 5 d; Kogo et al., 1997). When 35 residues
from the COOH terminus were deleted (1–127 and 14–127),
both LD and Golgi labeling were almost invisible.
Third, when the central hydrophobic domain (87–119)
was deleted from either 
 
a
 
 or 
 
b
 
 isoform, the mutants were
found in the Golgi, but not in LD (Fig. 5 e). Even when
cells were treated with BFA for 2 h, the labeling in LD was
hardly observed (not shown). Fourth, EGFP tagged to the
NH
 
2
 
 terminus alone (1–86), the COOH terminus alone
(127–162), or the hydrophobic domain alone (87–122)
showed cytosolic distribution (not shown). The result indi-
cates that the hydrophobic domain is important, but not
sufficient, for the LD localization.
 
Discussion
 
LD as a Membrane Domain
 
The present study showed that caveolin-2, especially its 
 
b
 
isoform, could localize in LD. Caveolin-2 is different from
the hitherto reported LD proteins (Londos et al., 1999;
Syu and Saltiel, 1999) in that it exists as an integral mem-
brane protein in the plasma membrane. Caveolin-2 as well
as other caveolins are supposed to anchor to the mem-
brane by the central hydrophobic domain with both NH
 
2
 
and COOH termini exposed to the cytoplasm (Parton,
1996). The result that the anti–caveolin-2 antibody, recog-
nizing the NH
 
2
 
-terminal segment (Das et al., 1999), deco-
rated only the P face of LD in the freeze-fracture replica
suggests that caveolin-2 takes the same orientation on the
LD surface as in the membrane. It is consistent with the
hypothesis that the LD surface is a half-membrane, or a
phospholipid monolayer, in which amphiphilic lipid mole-
cules exist with their hydrophilic and hydrophobic por-
tions oriented toward the cytoplasm and the LD content,
respectively (Zweytick et al., 2000).
The analysis of mutated caveolin-2 molecules supported
the above assumption. First, the NH
 
2
 
-terminal segment
(residues 70–86) was required for membrane attachment,
and its deletion abolished the localization in LD. Second,
the COOH-terminal segment (residues 120–150) appeared
necessary for the exit from ER, and its truncation caused
an increased retention in ER and a decreased distribution
in LD. These results indicate that both membrane attach-
ment and exit from ER are necessary for distribution in
LD. That is, caveolin-2 is likely to be translated in ER like
caveolin-1 (Monier et al., 1995), and then transported to
LD as a membrane protein. Two LD proteins, perilipin of
mammalian adipocytes (Londos et al., 1999) and oleosin
of plant seeds (Napier et al., 1996), are also synthesized in
the membrane-bound polyribosome.
It is noteworthy that the labeling for caveolin-2 was not
seen evenly in the LD surface, but was found in small clus-
ters both in cryosections and in freeze-fracture replicas. We
observed that the labeling for adipophilin shows the same
pattern in the LD surface (Nakamura, N., and T. Fujimoto,
unpublished observations). These results suggest that the
whole LD surface may not be homogenous and that some
segregation may occur in the half-membrane. Figure 5 (continues on next page) 
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Interestingly, a recent study revealed the presence of
unesterified cholesterol in LD (Prattes et al., 2000). Fur-
thermore, LD of eosinophils contain raft proteins related
to intracellular signaling, such as mitogen-activated protein
kinase and Lyn (Yu et al., 1998, 2000). Our study extended
the finding in that another raft molecule, caveolin-2, and
possibly other caveolins, can be distributed in the LD sur-
face. As a whole, these results suggest an intriguing possi-
bility that LD might be a novel membrane domain where
caveolins may functionally regulate signaling proteins.
 
Trafficking of Caveolins and LD
 
The mutagenesis study inferred that the hydrophobic do-
main of caveolin-2 (residues 87–119) is important for tar-
geting to LD. Even when this domain was deleted, the pro-
tein bound to the membrane and exited from ER, but it
was not seen in LD. Interestingly, oleosin and the hepatitis
C virus core protein, which can associate with LD, have a
hydrophobic domain flanked by hydrophilic/amphipathic
domains, and its deletion eliminated LD localization (van
Rooijen and Moloney, 1995; Hope and McLauchlan,
 
2000). Because sequence similarity does not exist between
the two proteins and caveolin-2, it may be a stretch of hy-
drophobic amino acids that dictates localization in LD.
The recruitment of caveolin-1 in BFA-treated cells may
also be due to the hydrophobic domain shared by all cave-
olins. However, caveolin-1 does not appear to have the
same degree of affinity to LD as caveolin-2. First, in cells
expressing caveolin-1 alone, its redistribution to LD after
the BFA treatment occurred slowly and only in occasional
cells. Second, without the BFA treatment, caveolin-1 was
not found in LD even when overexpressed. The LD local-
ization signal of caveolin-1 is likely to be less effective than
that of caveolin-2.
Endogenous caveolin-2 was not detected in LD in the
normal culture condition. It may be because caveolin-2
 
a
 
,
expressed predominantly in most cells, is less efficient than
caveolin-2
 
b
 
 in LD targeting. But the accumulation of cave-
olin-2 in LD of BFA-treated cells indicates an alternative
possibility; that is, caveolin-2, especially caveolin-2
 
a
 
, may
stay in LD transiently, so that its distribution in LD can
only be detected when the protein is expressed abundantly
Figure 5. (a) A diagram of caveolin-2
mutants and their distribution on
transient expression in HepG2. (b–e)
Distribution of mutants was ob-
served by anti–caveolin-2 labeling
(b, d, and e) or by EGFP (c) (green), and compared with LD, Golgi, or ER markers
(red). Arrows mark the labeling apparently encircling LD. Bars, 10 mm. (b) Single
amino acid replacements to examine the difference between a and b isoforms.
Even when methionine-14, the second translation initiation site, was replaced with
leucine (M14/L), or glycine-2, a putative myristoylation site, was replaced with ala-
nine (G2/A), distribution was not different from that of caveolin-2a. (c) NH2-termi-
nal deletion mutants fused to the COOH terminus of EGFP. Deletion of up to 69
residues (70–162) did not affect the LD localization, but further truncation (71–162)
caused cytosolic distribution. (d) COOH-terminal deletion mutants. For both a and
b isoforms, the distribution was not changed when the sequence up to the 150th res-
idue was maintained. As more amino acids were deleted, localization in LD and the
Golgi became less distinct, and a network-like labeling increased. The latter label-
ing was similar to that of calreticulin (result of 14–127 is shown). When ER was
made to retract from the cell edge (arrowheads) by nocodazole, the labeling for the
mutant showed a matching redistribution. (e) Caveolin-2b lacking the central hy-
drophobic domain [beta-TM(2)] was localized in the Golgi, labeled by anti–
GM130. Deletion of the same domain from caveolin-2a gave the same result. 
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or when its trafficking is perturbed. The morphological
continuity of ER and LD (Blanchette-Mackie et al., 1995)
and the persistence of LD labeling in BFA-treated cells in-
dicates that caveolin-2 goes directly from ER to LD. But
whether LD exists independently from the ER–Golgi
pathway, or LD is an intermediate compartment between
ER and the Golgi, is not known. The result of BFA experi-
ments may simply indicate that an excessive amount of ca-
veolin-2 in ER overflowed to LD. But BFA might also
block other pathways (e.g., from LD to the Golgi) and
have caused the LD retention. The two pathways are not
mutually exclusive and need further studies for definition.
Trafficking of caveolins to LD is important because it
may be linked to that of lipids. A testable question in this
context is whether the lipid composition of LD changes by
the presence of caveolins and/or by the BFA treatment,
which is now being examined in our lab. It is also impor-
tant to ask whether and how LD is related to the reported
trafficking routes of caveolin-1 (Conrad et al., 1995; Uit-
tenbogaard et al., 1998).
 
Concluding Remarks
 
Based on our results, we propose two new roles for LD.
One is as a membrane domain possibly related to signaling
and the other is as a transit point of lipid trafficking. LD
have been thought to be a reservoir of lipids in a few spe-
cialized cells, but they occur in many cells in reality. Our
result would be a starting point for further studies that
should shed light on this well-known, but enigmatic round
organelle.
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